Internal Medicine, Medical Oncology · Danville, IN
NPI
1215034525
Since 2006
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
100 Hospital Ln Ste 300
Danville, IN, 46122
Phone (317) 520-5510
Groups this clinician bills Medicare through
Medicare paid, 2024
$64K
691 services
Medicare patients, 2024
320
Average age 74
Drug cost, 2024
$3.2M
1,928 prescriptions
Company payments, 2025
$470
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sue C Tobin was code 99214 (office e&m - established), 284 times for 192 patients. In total Sue C Tobin billed 691 services in 17 codes, and Medicare paid $64K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-12-02.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 284 | 192 | $86.33 | $25K |
| 99215 Office E&M - Established | Office | 203 | 115 | $129.04 | $26K |
| 99213 Office E&M - Established | Office | 95 | 86 | $56.71 | $5,387 |
| G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 29 | 22 | $24.72 | $717 |
| 99205 Office E&M - New | Office | 23 | 23 | $167.54 | $3,853 |
By year: 2022 $73K for 885 services; 2023 $52K for 648 services; 2024 $64K for 691 services.
Medicare prescription drug claims, 2024
In 2024, the drug Sue C Tobin prescribed most often to Medicare patients was Anastrozole, with 587 prescriptions and refills. In total Sue C Tobin wrote 1,928 Medicare prescriptions that cost $3.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 587 | 1,482 | 160 | $30K |
| Exemestane Generic | 167 | 346 | 44 | $38K |
| Letrozole Generic | 158 | 326 | 53 | $6,491 |
| Ondansetron Hcl Generic | 111 | 113 | 54 | $714 |
| Hydroxyurea Generic | 85 | 127 | 18 | $1,588 |
| Tamoxifen Citrate Generic | 51 | 120 | 16 | $1,207 |
| Potassium Chloride Generic | 39 | 45 | 17 | $562 |
| Kisqali Ribociclib Succinate | 38 | 40 | Under 11 | $622K |
| Ibrance Palbociclib | 36 | 36 | Under 11 | $579K |
| Risedronate Sodium Generic | 33 | 42 | Under 11 | $1,966 |
| Prednisone Generic | 33 | 33 | 21 | $103 |
| Eliquis Apixaban | 31 | 35 | Under 11 | $18K |
| Omeprazole Generic | 31 | 33 | Under 11 | $125 |
| Acyclovir Generic | 30 | 37 | Under 11 | $232 |
| Revlimid Lenalidomide | 28 | 28 | Under 11 | $473K |
Brand drugs: 282 claims; generic drugs: 1,646 claims; opioid claims: 21.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sue C Tobin $470 ($470 in general payments such as food, travel and fees) from 11 companies. The largest payer was Gilead Sciences, Inc. with $85.08.
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. GILD | 4 | $85.08 |
| Novartis Pharmaceuticals Corporation NVS | 3 | $84.29 |
| AstraZeneca Pharmaceuticals LP AZN | 3 | $66.95 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 2 | $50.34 |
| Pfizer Inc. PFE | 2 | $45.83 |
| Jazz Pharmaceuticals Inc. JAZZ | 1 | $31.84 |
| Adaptive Biotechnologies Corporation ADPT | 1 | $28.95 |
| Syndax Pharmaceuticals, Inc. SNDX | 1 | $26.95 |
| Legend Biotech USA Inc. LEGN | 1 | $21.45 |
| GlaxoSmithKline, LLC. GSK | 1 | $14.63 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.